| Identification | Back Directory | [Name]
5-Pyrimidineacetamide, α-[[(2S)-2-chloro-2-fluoroacetyl][4-(5-isoxazolyl)phenyl]amino]-N-(4,4-difluorocyclohexyl)-, (αS)- | [CAS]
2735704-33-1 | [Synonyms]
INSCoV-614(1B)
5-Pyrimidineacetamide, α-[[(2S)-2-chloro-2-fluoroacetyl][4-(5-isoxazolyl)phenyl]amino]-N-(4,4-difluorocyclohexyl)-, (αS)- | [Molecular Formula]
C23H21ClF3N5O3 | [MOL File]
2735704-33-1.mol | [Molecular Weight]
507.9 |
| Hazard Information | Back Directory | [Uses]
INSCoV-614(1B) is a potent inhibitor of Mpro (3CLpro). Proteases (PL pro and 3CL pro) are involved with transcription and replication of the virus. INSCoV-614(1B) has the potential for the research of SARS-CoV-2 infection (extracted from patent WO2021219089A1)[1]. | [References]
[1] Aleksandrs Zavoronkovs, et al. Sars-cov-2 inhibitors having covalent modifications for treating coronavirus infections. Patent WO2021219089A1. |
|
|